Acurx Pharmaceuticals, Inc. (ACXP) Operating cash flow 2020–2025
Acurx Pharmaceuticals, Inc. (ACXP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$6.8MFY2025 · since FY2020: -$3.4M → -$6.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.8M | +34.6% |
| FY2024 | -$10.4M | -5.9% |
| FY2023 | -$9.8M | -29.9% |
| FY2022 | -$7.5M | -50.4% |
| FY2021 | -$5.0M | -49.6% |
| FY2020 | -$3.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ACXP financial trends
ACXP RevenueACXP Net incomeACXP Net marginACXP Gross profitACXP Gross marginACXP Operating incomeACXP Operating marginACXP Free cash flowACXP Capital expendituresACXP Return on equityACXP Stock buybacksACXP Dividends paidACXP Total assetsACXP Total liabilitiesACXP Shareholders’ equityACXP overview →